Debernardi S - Search Results

1

Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine.

Daulton E, Wicaksono AN, Tiele A, Kocher HM, Debernardi S, Crnogorac-Jurcevic T, Covington JA. Daulton E, et al. Among authors: debernardi s. Talanta. 2021 Jan 1;221:121604. doi: 10.1016/j.talanta.2020.121604. Epub 2020 Sep 2. Talanta. 2021. PMID: 33076134

2

Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma.

Debernardi S, Massat NJ, Radon TP, Sangaralingam A, Banissi A, Ennis DP, Dowe T, Chelala C, Pereira SP, Kocher HM, Young BD, Bond-Smith G, Hutchins R, Crnogorac-Jurcevic T. Debernardi S, et al. Am J Cancer Res. 2015 Oct 15;5(11):3455-66. eCollection 2015. Am J Cancer Res. 2015. PMID: 26807325 Free PMC article.

3

Demographic, clinical, and pathological features of early onset pancreatic cancer patients.

Ntala C, Debernardi S, Feakins RM, Crnogorac-Jurcevic T. Ntala C, et al. Among authors: debernardi s. BMC Gastroenterol. 2018 Sep 12;18(1):139. doi: 10.1186/s12876-018-0866-z. BMC Gastroenterol. 2018. PMID: 30208959 Free PMC article.

4

A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.

Debernardi S, O'Brien H, Algahmdi AS, Malats N, Stewart GD, Plješa-Ercegovac M, Costello E, Greenhalf W, Saad A, Roberts R, Ney A, Pereira SP, Kocher HM, Duffy S, Blyuss O, Crnogorac-Jurcevic T. Debernardi S, et al. PLoS Med. 2020 Dec 10;17(12):e1003489. doi: 10.1371/journal.pmed.1003489. eCollection 2020 Dec. PLoS Med. 2020. PMID: 33301466 Free PMC article.

5

Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis.

Debernardi S, Blyuss O, Rycyk D, Srivastava K, Jeon CY, Cai H, Cai Q, Shu XO, Crnogorac-Jurcevic T. Debernardi S, et al. Int J Cancer. 2023 Feb 15;152(4):769-780. doi: 10.1002/ijc.34287. Epub 2022 Sep 23. Int J Cancer. 2023. PMID: 36093581 Free PMC article.

6

Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias.

Raghavan M, Lillington DM, Skoulakis S, Debernardi S, Chaplin T, Foot NJ, Lister TA, Young BD. Raghavan M, et al. Among authors: debernardi s. Cancer Res. 2005 Jan 15;65(2):375-8. Cancer Res. 2005. PMID: 15695375

7

Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias.

Fitzgibbon J, Smith LL, Raghavan M, Smith ML, Debernardi S, Skoulakis S, Lillington D, Lister TA, Young BD. Fitzgibbon J, et al. Among authors: debernardi s. Cancer Res. 2005 Oct 15;65(20):9152-4. doi: 10.1158/0008-5472.CAN-05-2017. Cancer Res. 2005. PMID: 16230371

8

Understanding cancer at the chromosome level: 40 years of progress.

Debernardi S, Lillington D, Young BD. Debernardi S, et al. Eur J Cancer. 2004 Sep;40(13):1960-7. doi: 10.1016/j.ejca.2004.06.007. Eur J Cancer. 2004. PMID: 15315804

9

Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia.

Dixon-McIver A, East P, Mein CA, Cazier JB, Molloy G, Chaplin T, Andrew Lister T, Young BD, Debernardi S. Dixon-McIver A, et al. Among authors: debernardi s. PLoS One. 2008 May 14;3(5):e2141. doi: 10.1371/journal.pone.0002141. PLoS One. 2008. PMID: 18478077 Free PMC article.

10

MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis.

Debernardi S, Skoulakis S, Molloy G, Chaplin T, Dixon-McIver A, Young BD. Debernardi S, et al. Leukemia. 2007 May;21(5):912-6. doi: 10.1038/sj.leu.2404605. Epub 2007 Mar 1. Leukemia. 2007. PMID: 17330104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page